|
USP10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.422670E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.341200E-01 |
| Normal-vs-Stage2 |
1.393610E-01 |
| Normal-vs-Stage3 |
3.258000E-02 |
| Normal-vs-Stage4 |
3.309400E-01 |
| Stage1-vs-Stage2 |
4.843400E-01 |
| Stage1-vs-Stage3 |
7.580000E-02 |
| Stage1-vs-Stage4 |
6.524800E-01 |
| Stage2-vs-Stage3 |
5.003600E-01 |
| Stage2-vs-Stage4 |
9.506200E-01 |
| Stage3-vs-Stage4 |
5.688200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.413500E-04 |
| Normal-vs-AfricanAmerican |
5.588400E-01 |
| Normal-vs-Asian |
4.141800E-01 |
| Caucasian-vs-AfricanAmerican |
7.558400E-02 |
| Caucasian-vs-Asian |
6.533800E-01 |
| AfricanAmerican-vs-Asian |
4.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.504420E-02 |
| Normal-vs-Female |
1.844350E-03 |
| Male-vs-Female |
1.222390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.335400E-01 |
| Normal-vs-Extreme_Weight |
1.837950E-01 |
| Normal-vs-Obese |
2.999600E-03 |
| Normal-vs-Extreme_Obese |
8.409800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.231000E-01 |
| Normal_Weight-vs-Obese |
1.100620E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.635000E-01 |
| Extreme_Weight-vs-Obese |
9.710400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.574400E-01 |
| Obese-vs-Extreme_Obese |
1.415030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.467900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.370700E-04 |
| Normal-vs-Age(61-80Yrs) |
6.789600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.254600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.876800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.986820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.684400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.729580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.922400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.710160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.264900E-03 |
| Normal-VS-Type2 PRCC |
2.600800E-01 |
| Normal-VS-KIRP CIMP |
1.394630E-01 |
| Normal-VS-Unclassified PRCC |
2.680200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.342200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.784200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.314200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.206600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.983600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.884400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.295600E-01 |
| Normal-vs-N1 |
1.667600E-02 |
| Normal-vs-N2 |
3.694400E-02 |
| N0-vs-N1 |
1.316640E-01 |
| N0-vs-N2 |
3.385000E-01 |
| N1-vs-N2 |
7.426300E-02 |
|
|
